This report aims to provide a comprehensive presentation of the global market for Valsartan API study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Valsartan API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Valsartan API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Valsartan API companies in 2021 (%)
The global Valsartan API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity Above 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Valsartan API include Biophore India Pharmaceuticals, Zydus Lifesciences, Harman Finochem, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Macleods Pharmaceuticals, MSN Life Sciences, Mylan Laboratories and Dr. Reddy's Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Valsartan API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Valsartan API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Valsartan API Market Segment Percentages, by Type, 2021 (%)
Purity Above 99%
Purity Below 99%
Global Valsartan API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Valsartan API Market Segment Percentages, by Application, 2021 (%)
Tablet
Capsule
Global Valsartan API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Valsartan API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Valsartan API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Valsartan API revenues share in global market, 2021 (%)
Key companies Valsartan API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Valsartan API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biophore India Pharmaceuticals
Zydus Lifesciences
Harman Finochem
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Macleods Pharmaceuticals
MSN Life Sciences
Mylan Laboratories
Dr. Reddy's Laboratories
Ipca Laboratories
Divis Laboratories
Novartis
Lupin Ltd
Jubilant Generics
Alembic Pharmaceuticals
Aurobindo Pharma
Chromo Laboratories India
Hetero Labs Ltd
Krka
Zhejiang Tianyu Pharmaceutical
Zhejiang Second Pharma
Zhuhai Rundu Pharmaceutical
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Valsartan API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Valsartan API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Valsartan API Overall Market Size
2.1 Global Valsartan API Market Size: 2021 VS 2028
2.2 Global Valsartan API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Valsartan API Sales: 2017-2028
3 Company Landscape
3.1 Top Valsartan API Players in Global Market
3.2 Top Global Valsartan API Companies Ranked by Revenue
3.3 Global Valsartan API Revenue by Companies
3.4 Global Valsartan API Sales by Companies
3.5 Global Valsartan API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Valsartan API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Valsartan API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Valsartan API Players in Global Market
3.8.1 List of Global Tier 1 Valsartan API Companies
3.8.2 List of Global Tier 2 and Tier 3 Valsartan API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Valsartan API Market Size Markets, 2021 & 2028
4.1.2 Purity Above 99%
4.1.3 Purity Below 99%
4.2 By Type - Global Valsartan API Revenue & Forecasts
4.2.1 By Type - Global Valsartan API Revenue, 2017-2022
4.2.2 By Type - Global Valsartan API Revenue, 2023-2028
4.2.3 By Type - Global Valsartan API Revenue Market Share, 2017-2028
4.3 By Type - Global Valsartan API Sales & Forecasts
4.3.1 By Type - Global Valsartan API Sales, 2017-2022
4.3.2 By Type - Global Valsartan API Sales, 2023-2028
4.3.3 By Type - Global Valsartan API Sales Market Share, 2017-2028
4.4 By Type - Global Valsartan API Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Valsartan API Market Size, 2021 & 2028
5.1.2 Tablet
5.1.3 Capsule
5.2 By Application - Global Valsartan API Revenue & Forecasts
5.2.1 By Application - Global Valsartan API Revenue, 2017-2022
5.2.2 By Application - Global Valsartan API Revenue, 2023-2028
5.2.3 By Application - Global Valsartan API Revenue Market Share, 2017-2028
5.3 By Application - Global Valsartan API Sales & Forecasts
5.3.1 By Application - Global Valsartan API Sales, 2017-2022
5.3.2 By Application - Global Valsartan API Sales, 2023-2028
5.3.3 By Application - Global Valsartan API Sales Market Share, 2017-2028
5.4 By Application - Global Valsartan API Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Valsartan API Market Size, 2021 & 2028
6.2 By Region - Global Valsartan API Revenue & Forecasts
6.2.1 By Region - Global Valsartan API Revenue, 2017-2022
6.2.2 By Region - Global Valsartan API Revenue, 2023-2028
6.2.3 By Region - Global Valsartan API Revenue Market Share, 2017-2028
6.3 By Region - Global Valsartan API Sales & Forecasts
6.3.1 By Region - Global Valsartan API Sales, 2017-2022
6.3.2 By Region - Global Valsartan API Sales, 2023-2028
6.3.3 By Region - Global Valsartan API Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Valsartan API Revenue, 2017-2028
6.4.2 By Country - North America Valsartan API Sales, 2017-2028
6.4.3 US Valsartan API Market Size, 2017-2028
6.4.4 Canada Valsartan API Market Size, 2017-2028
6.4.5 Mexico Valsartan API Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Valsartan API Revenue, 2017-2028
6.5.2 By Country - Europe Valsartan API Sales, 2017-2028
6.5.3 Germany Valsartan API Market Size, 2017-2028
6.5.4 France Valsartan API Market Size, 2017-2028
6.5.5 U.K. Valsartan API Market Size, 2017-2028
6.5.6 Italy Valsartan API Market Size, 2017-2028
6.5.7 Russia Valsartan API Market Size, 2017-2028
6.5.8 Nordic Countries Valsartan API Market Size, 2017-2028
6.5.9 Benelux Valsartan API Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Valsartan API Revenue, 2017-2028
6.6.2 By Region - Asia Valsartan API Sales, 2017-2028
6.6.3 China Valsartan API Market Size, 2017-2028
6.6.4 Japan Valsartan API Market Size, 2017-2028
6.6.5 South Korea Valsartan API Market Size, 2017-2028
6.6.6 Southeast Asia Valsartan API Market Size, 2017-2028
6.6.7 India Valsartan API Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Valsartan API Revenue, 2017-2028
6.7.2 By Country - South America Valsartan API Sales, 2017-2028
6.7.3 Brazil Valsartan API Market Size, 2017-2028
6.7.4 Argentina Valsartan API Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Valsartan API Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Valsartan API Sales, 2017-2028
6.8.3 Turkey Valsartan API Market Size, 2017-2028
6.8.4 Israel Valsartan API Market Size, 2017-2028
6.8.5 Saudi Arabia Valsartan API Market Size, 2017-2028
6.8.6 UAE Valsartan API Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Biophore India Pharmaceuticals
7.1.1 Biophore India Pharmaceuticals Corporate Summary
7.1.2 Biophore India Pharmaceuticals Business Overview
7.1.3 Biophore India Pharmaceuticals Valsartan API Major Product Offerings
7.1.4 Biophore India Pharmaceuticals Valsartan API Sales and Revenue in Global (2017-2022)
7.1.5 Biophore India Pharmaceuticals Key News
7.2 Zydus Lifesciences
7.2.1 Zydus Lifesciences Corporate Summary
7.2.2 Zydus Lifesciences Business Overview
7.2.3 Zydus Lifesciences Valsartan API Major Product Offerings
7.2.4 Zydus Lifesciences Valsartan API Sales and Revenue in Global (2017-2022)
7.2.5 Zydus Lifesciences Key News
7.3 Harman Finochem
7.3.1 Harman Finochem Corporate Summary
7.3.2 Harman Finochem Business Overview
7.3.3 Harman Finochem Valsartan API Major Product Offerings
7.3.4 Harman Finochem Valsartan API Sales and Revenue in Global (2017-2022)
7.3.5 Harman Finochem Key News
7.4 Sun Pharmaceutical Industries
7.4.1 Sun Pharmaceutical Industries Corporate Summary
7.4.2 Sun Pharmaceutical Industries Business Overview
7.4.3 Sun Pharmaceutical Industries Valsartan API Major Product Offerings
7.4.4 Sun Pharmaceutical Industries Valsartan API Sales and Revenue in Global (2017-2022)
7.4.5 Sun Pharmaceutical Industries Key News
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Corporate Summary
7.5.2 Teva Pharmaceutical Industries Business Overview
7.5.3 Teva Pharmaceutical Industries Valsartan API Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Valsartan API Sales and Revenue in Global (2017-2022)
7.5.5 Teva Pharmaceutical Industries Key News
7.6 Macleods Pharmaceuticals
7.6.1 Macleods Pharmaceuticals Corporate Summary
7.6.2 Macleods Pharmaceuticals Business Overview
7.6.3 Macleods Pharmaceuticals Valsartan API Major Product Offerings
7.6.4 Macleods Pharmaceuticals Valsartan API Sales and Revenue in Global (2017-2022)
7.6.5 Macleods Pharmaceuticals Key News
7.7 MSN Life Sciences
7.7.1 MSN Life Sciences Corporate Summary
7.7.2 MSN Life Sciences Business Overview
7.7.3 MSN Life Sciences Valsartan API Major Product Offerings
7.7.4 MSN Life Sciences Valsartan API Sales and Revenue in Global (2017-2022)
7.7.5 MSN Life Sciences Key News
7.8 Mylan Laboratories
7.8.1 Mylan Laboratories Corporate Summary
7.8.2 Mylan Laboratories Business Overview
7.8.3 Mylan Laboratories Valsartan API Major Product Offerings
7.8.4 Mylan Laboratories Valsartan API Sales and Revenue in Global (2017-2022)
7.8.5 Mylan Laboratories Key News
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Corporate Summary
7.9.2 Dr. Reddy's Laboratories Business Overview
7.9.3 Dr. Reddy's Laboratories Valsartan API Major Product Offerings
7.9.4 Dr. Reddy's Laboratories Valsartan API Sales and Revenue in Global (2017-2022)
7.9.5 Dr. Reddy's Laboratories Key News
7.10 Ipca Laboratories
7.10.1 Ipca Laboratories Corporate Summary
7.10.2 Ipca Laboratories Business Overview
7.10.3 Ipca Laboratories Valsartan API Major Product Offerings
7.10.4 Ipca Laboratories Valsartan API Sales and Revenue in Global (2017-2022)
7.10.5 Ipca Laboratories Key News
7.11 Divis Laboratories
7.11.1 Divis Laboratories Corporate Summary
7.11.2 Divis Laboratories Valsartan API Business Overview
7.11.3 Divis Laboratories Valsartan API Major Product Offerings
7.11.4 Divis Laboratories Valsartan API Sales and Revenue in Global (2017-2022)
7.11.5 Divis Laboratories Key News
7.12 Novartis
7.12.1 Novartis Corporate Summary
7.12.2 Novartis Valsartan API Business Overview
7.12.3 Novartis Valsartan API Major Product Offerings
7.12.4 Novartis Valsartan API Sales and Revenue in Global (2017-2022)
7.12.5 Novartis Key News
7.13 Lupin Ltd
7.13.1 Lupin Ltd Corporate Summary
7.13.2 Lupin Ltd Valsartan API Business Overview
7.13.3 Lupin Ltd Valsartan API Major Product Offerings
7.13.4 Lupin Ltd Valsartan API Sales and Revenue in Global (2017-2022)
7.13.5 Lupin Ltd Key News
7.14 Jubilant Generics
7.14.1 Jubilant Generics Corporate Summary
7.14.2 Jubilant Generics Business Overview
7.14.3 Jubilant Generics Valsartan API Major Product Offerings
7.14.4 Jubilant Generics Valsartan API Sales and Revenue in Global (2017-2022)
7.14.5 Jubilant Generics Key News
7.15 Alembic Pharmaceuticals
7.15.1 Alembic Pharmaceuticals Corporate Summary
7.15.2 Alembic Pharmaceuticals Business Overview
7.15.3 Alembic Pharmaceuticals Valsartan API Major Product Offerings
7.15.4 Alembic Pharmaceuticals Valsartan API Sales and Revenue in Global (2017-2022)
7.15.5 Alembic Pharmaceuticals Key News
7.16 Aurobindo Pharma
7.16.1 Aurobindo Pharma Corporate Summary
7.16.2 Aurobindo Pharma Business Overview
7.16.3 Aurobindo Pharma Valsartan API Major Product Offerings
7.16.4 Aurobindo Pharma Valsartan API Sales and Revenue in Global (2017-2022)
7.16.5 Aurobindo Pharma Key News
7.17 Chromo Laboratories India
7.17.1 Chromo Laboratories India Corporate Summary
7.17.2 Chromo Laboratories India Business Overview
7.17.3 Chromo Laboratories India Valsartan API Major Product Offerings
7.17.4 Chromo Laboratories India Valsartan API Sales and Revenue in Global (2017-2022)
7.17.5 Chromo Laboratories India Key News
7.18 Hetero Labs Ltd
7.18.1 Hetero Labs Ltd Corporate Summary
7.18.2 Hetero Labs Ltd Business Overview
7.18.3 Hetero Labs Ltd Valsartan API Major Product Offerings
7.18.4 Hetero Labs Ltd Valsartan API Sales and Revenue in Global (2017-2022)
7.18.5 Hetero Labs Ltd Key News
7.19 Krka
7.19.1 Krka Corporate Summary
7.19.2 Krka Business Overview
7.19.3 Krka Valsartan API Major Product Offerings
7.19.4 Krka Valsartan API Sales and Revenue in Global (2017-2022)
7.19.5 Krka Key News
7.20 Zhejiang Tianyu Pharmaceutical
7.20.1 Zhejiang Tianyu Pharmaceutical Corporate Summary
7.20.2 Zhejiang Tianyu Pharmaceutical Business Overview
7.20.3 Zhejiang Tianyu Pharmaceutical Valsartan API Major Product Offerings
7.20.4 Zhejiang Tianyu Pharmaceutical Valsartan API Sales and Revenue in Global (2017-2022)
7.20.5 Zhejiang Tianyu Pharmaceutical Key News
7.21 Zhejiang Second Pharma
7.21.1 Zhejiang Second Pharma Corporate Summary
7.21.2 Zhejiang Second Pharma Business Overview
7.21.3 Zhejiang Second Pharma Valsartan API Major Product Offerings
7.21.4 Zhejiang Second Pharma Valsartan API Sales and Revenue in Global (2017-2022)
7.21.5 Zhejiang Second Pharma Key News
7.22 Zhuhai Rundu Pharmaceutical
7.22.1 Zhuhai Rundu Pharmaceutical Corporate Summary
7.22.2 Zhuhai Rundu Pharmaceutical Business Overview
7.22.3 Zhuhai Rundu Pharmaceutical Valsartan API Major Product Offerings
7.22.4 Zhuhai Rundu Pharmaceutical Valsartan API Sales and Revenue in Global (2017-2022)
7.22.5 Zhuhai Rundu Pharmaceutical Key News
8 Global Valsartan API Production Capacity, Analysis
8.1 Global Valsartan API Production Capacity, 2017-2028
8.2 Valsartan API Production Capacity of Key Manufacturers in Global Market
8.3 Global Valsartan API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Valsartan API Supply Chain Analysis
10.1 Valsartan API Industry Value Chain
10.2 Valsartan API Upstream Market
10.3 Valsartan API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Valsartan API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|